Pattern of Intermediate Uveitis in an Egyptian Cohort.
Eiman Abd El LatifAhmed Shawkat AbdelhalimAhmed Samir MontasserMohamed Hassan SaidMohammed Shikhoun AhmedMarwa Abdel Kader Fouly GalalWalid IbrahimMohamed Samy Abd ElazizAmr Fathi AbuelkheirHossameldeen ElbarbaryAyman M Abdelrahman ElsayedAyman LotfyOsama A ElmorsyAmr A Gab-AllaRagai Magdy HatataAmir Alyeldin Hassan AbousamraMahmoud Mohamed FaroukMolham A ElbakaryAmr Mahmoud AwaraIbrahim AmerWalid Mohamed Abd Elraouf ElzawahryHazem W KandilOmar A BarradaKareem Bakr ElessawyMohamed A ZayedHazem El HennawiMohamed A TawfikPublished in: Ocular immunology and inflammation (2019)
Purpose: To describe the clinical experience with intermediate uveitis at six Egyptian tertiary eye centers.Methods: A multicenter retrospective chart review of all patients with intermediate uveitis seen at six ocular inflammation referral clinics in Egypt between January 2010 and January 2017.Results: The study included a total of 781 patients with intermediate uveitis. The study cohort comprised of 282 male and 499 female patients. In over half of our cohort (58.77%), no specific cause could be confirmed. The remaining patients had sarcoidosis (16.26%), tuberculosis (14.85%), multiple sclerosis (9.09%), and TINU (1.02%). By the end of our study, 62% of the affected eyes had a BCVA better than 20/40Conclusion: More than 40% of our patients with intermediate uveitis had sarcoidosis, tuberculosis, multiple sclerosis, or TINU as the underlying etiology. Owing to their potential morbidity, these diseases need to be considered in Egyptian patients presenting with intermediate uveitis.
Keyphrases
- juvenile idiopathic arthritis
- multiple sclerosis
- ankylosing spondylitis
- end stage renal disease
- primary care
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- oxidative stress
- prognostic factors
- rheumatoid arthritis
- cross sectional
- clinical trial
- systemic lupus erythematosus
- risk assessment
- disease activity
- climate change